← Leaderboards
Joshua Wiley Knowles
Stanford University
$7,436,668
Attributed
$8,087,544
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,087,544 · 5
By mechanism
R01$7,778,744 · 4
R03$308,800 · 1
Top collaborators
- Erik Ingelsson2 shared
Most similar at Stanford University
Same institution · by research overlap
- Seung K Kim$34,748,747
- Thomas None Quertermous$63,279,401
- Erik Ingelsson$3,706,797
- Purveshkumar Khatri$4,903,801
- Roarke Alexander Kamber$1,997,066
Others in their field
Other Emerging Leaders on “Insulin Resistance”
- Barbara Halina Braffett · George Washington University$17,257,975
- Ionut Bebu · George Washington University$14,057,850
- Vaia Lida Chatzi · University Of Southern California$6,334,730
- Petter Bjornstad · University Of Colorado Denver$6,184,413
- Pankaj Arora · University Of Alabama At Birmingham$5,870,690
- Ming Xu · University Of Connecticut Sch Of Med/Dnt$5,476,967
Research focus
Insulin ResistanceCellsGenesGlucose UptakeIn VivoPhenotypeInsulinTraitGenome Wide Association StudyKnock-DownIn VitroCardiovascular DiseasesAdipocytesNon-Insulin-Dependent Diabetes MellitusMolecularTissuesExperimental StudyFatty Acid Glycerol EstersLipolysisGeneticMitochondriaLiverClustered Regularly Interspaced Short Palindromic RepeatsMediating
Grant awards (15)
Molecular Mechanisms of Insulin Resistance Associated Loci$563,200
R01 · FY2025 · DK · contact PI
Molecular Mechanisms of Insulin Resistance Associated Loci$640,930
R01 · FY2024 · DK · contact PI
Synergizing Common Fund Data from MoTrPAC and LINCS for the Discovery of Novel Exercise Mimetic Drugs$308,800
R03 · FY2024 · OD · contact PI
Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies$620,254
R01 · FY2023 · DK · contact PI
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction$484,186
R01 · FY2023 · DK · contact PI
Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies$617,918
R01 · FY2022 · DK · contact PI
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction$499,314
R01 · FY2022 · DK · contact PI
Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies$635,332
R01 · FY2021 · DK · contact PI
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction$496,339
R01 · FY2021 · DK · contact PI
Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies$648,352
R01 · FY2020 · DK · contact PI
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction$488,005
R01 · FY2020 · DK · contact PI
Beyond GWAS of insulin resistance: An integrated approach to translate genetic association to function$415,512
R01 · FY2020 · DK · contact PI
Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies$653,400
R01 · FY2019 · DK · contact PI
Beyond GWAS of insulin resistance: An integrated approach to translate genetic association to function$549,354
R01 · FY2019 · DK · contact PI
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction$466,648
R01 · FY2019 · DK · contact PI